Literature DB >> 22249857

Toxic effects of nicotinamide methylation on mouse brain striatum neuronal cells and its relation to manganese.

Yayoi Mori1, Akiko Sugawara, Masayoshi Tsuji, Takeyasu Kakamu, Satoshi Tsuboi, Hideyuki Kanda, Takehito Hayakawa, Tetsuhito Fukushima.   

Abstract

OBJECTIVE: It is well known that manganese (Mn) exposure is involved in parkinsonism. The aim of our study was to test the hypotheses that Mn affects nicotinamide N-methyltransferase (NNMT) activity, increases the metabolism of nicotinamide (NA) to 1-methylnicotinamide (MNA), and leads to neurocytotoxicity.
METHODS: Following demonstration of the effects of Mn concentrations on the survival rate of Mouse CD1 brain striatum neuronal cells (MS cells), the effect of Mn on NNMT activity was investigated by comparing the difference in the amount of MNA produced after various Mn concentrations were added to mouse brain cytosol fractions as an enzyme solution. Toxicity induced by MNA and its precursor NA on MS cells was measured.
RESULTS: The survival rate of MS cells decreased significantly with increasing concentrations of Mn in the culture medium. With respect to the influence of Mn on NNMT activity, NNMT activity increased significantly at Mn concentrations of 1 μmol/mg protein. MNA and NA neurotoxicity were compared by comparing cell survival rate. Cell survival rate dropped significantly when the cells were cultivated with 10 mM of MNA. There was also a tendency for the survival rate to fall following the addition of 10 mM NA; however, the difference with the control was not significant.
CONCLUSIONS: Our study suggests the possibility that Mn causes increased NNMT activity, thereby increasing MNA levels in the brain and bringing about neuron death. Daily absorption of Mn and NA may thus contribute to idiopathic Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249857      PMCID: PMC3437358          DOI: 10.1007/s12199-011-0262-6

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  27 in total

1.  Nicotinamide (vitamin B3) as an effective antioxidant against oxidative damage in rat brain mitochondria.

Authors:  J P Kamat; T P Devasagayam
Journal:  Redox Rep       Date:  1999       Impact factor: 4.412

2.  Neurotoxicity of nicotinamide derivatives: their role in the aetiology of Parkinson's disease.

Authors:  J M Willets; J Lunec; A C Williams; H R Griffiths
Journal:  Biochem Soc Trans       Date:  1993-08       Impact factor: 5.407

Review 3.  Autotoxicity, methylation and a road to the prevention of Parkinson's disease.

Authors:  Adrian C Williams; David B Ramsden
Journal:  J Clin Neurosci       Date:  2005-01       Impact factor: 1.961

4.  Human nicotinamide N-methyltransferase pharmacogenetics: gene sequence analysis and promoter characterization.

Authors:  L Yan; D M Otterness; R M Weinshilboum
Journal:  Pharmacogenetics       Date:  1999-06

5.  Possible role of 1-methylnicotinamide in the pathogenesis of Parkinson's disease.

Authors:  Tetsuhito Fukushima; Akihiko Kaetsu; Heejin Lim; Masaki Moriyama
Journal:  Exp Toxicol Pathol       Date:  2002-02

6.  The effect of heavy metals on nicotinamideN-methyltransferase activityin vitro relating to Parkinson's disease.

Authors:  Akiko Sugawara; Hiroko Yokoyama; Mitsuhiro Ohta; Takafumi Maeda; Kazuko Tanaka; Tetsuhito Fukushima
Journal:  Environ Health Prev Med       Date:  2005-07       Impact factor: 3.674

7.  Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature.

Authors:  S Nagatomo; F Umehara; K Hanada; Y Nobuhara; S Takenaga; K Arimura; M Osame
Journal:  J Neurol Sci       Date:  1999-01-01       Impact factor: 3.181

8.  Nicotinamide and 1-methylnicotinamide reduce homocysteine neurotoxicity in primary cultures of rat cerebellar granule cells.

Authors:  Marta Slomka; Elzbieta Zieminska; Jerzy Lazarewicz
Journal:  Acta Neurobiol Exp (Wars)       Date:  2008       Impact factor: 1.579

9.  Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia.

Authors:  Gregg D Stanwood; Duncan B Leitch; Valentina Savchenko; Jane Wu; Vanessa A Fitsanakis; Douglas J Anderson; Jeannette N Stankowski; Michael Aschner; BethAnn McLaughlin
Journal:  J Neurochem       Date:  2009-05-05       Impact factor: 5.372

10.  Relationship between blood levels of heavy metals and Parkinson's disease in China.

Authors:  Tetsuhito Fukushima; Xiaodong Tan; Yunwen Luo; Hideyuki Kanda
Journal:  Neuroepidemiology       Date:  2009-11-05       Impact factor: 3.282

View more
  3 in total

1.  Physiological Study on Association between Nicotinamide N-Methyltransferase Gene Polymorphisms and Hyperlipidemia.

Authors:  Xiao-Juan Zhu; Ya-Jun Lin; Wei Chen; Ya-Hui Wang; Li-Qiang Qiu; Can-Xin Cai; Qun Xiong; Fei Chen; Li-Hui Chen; Qiong Zhou; Jiang-Hua Li
Journal:  Biomed Res Int       Date:  2016-11-23       Impact factor: 3.411

2.  Metabolic tracing reveals novel adaptations to skeletal muscle cell energy production pathways in response to NAD + depletion.

Authors:  Lucy A Oakey; Rachel S Fletcher; Yasir S Elhassan; David M Cartwright; Craig L Doig; Antje Garten; Alpesh Thakker; Oliver D K Maddocks; Tong Zhang; Daniel A Tennant; Christian Ludwig; Gareth G Lavery
Journal:  Wellcome Open Res       Date:  2018-11-15

3.  Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signalling.

Authors:  M G Thomas; M Saldanha; R J Mistry; D T Dexter; D B Ramsden; R B Parsons
Journal:  Cell Death Dis       Date:  2013-06-13       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.